Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Rxo (RXO) EBT Margin (2021 - 2025)

Historic EBT Margin for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to 3.47%.

  • Rxo's EBT Margin fell 14900.0% to 3.47% in Q4 2025 from the same period last year, while for Dec 2025 it was 2.0%, marking a year-over-year increase of 46800.0%. This contributed to the annual value of 2.0% for FY2025, which is 46800.0% up from last year.
  • Rxo's EBT Margin amounted to 3.47% in Q4 2025, which was down 14900.0% from 1.06% recorded in Q3 2025.
  • Rxo's 5-year EBT Margin high stood at 4.81% for Q2 2022, and its period low was 23.27% during Q3 2024.
  • Over the past 5 years, Rxo's median EBT Margin value was 0.42% (recorded in 2022), while the average stood at 1.06%.
  • Per our database at Business Quant, Rxo's EBT Margin crashed by -229600bps in 2024 and then soared by 222100bps in 2025.
  • Rxo's EBT Margin (Quarter) stood at 4.14% in 2021, then plummeted by -113bps to 0.54% in 2022, then skyrocketed by 176bps to 0.41% in 2023, then plummeted by -584bps to 1.98% in 2024, then crashed by -75bps to 3.47% in 2025.
  • Its last three reported values are 3.47% in Q4 2025, 1.06% for Q3 2025, and 0.7% during Q2 2025.